Inactivation of inducible nitric oxide synthase protects intestinal pacemaker cells from postoperative damage

Hiroe Yanagida1, Kenton M Sanders, Sean M Ward

  • 1Department of Physiology and Cell Biology, University of Nevada School of Medicine, Reno, NV 89557, USA.

Insights

Preoperative inhibition of inducible nitric oxide synthase (iNOS) protects interstitial cells of Cajal (ICC) from surgical damage. This strategy mitigates postoperative gastrointestinal dysmotility and paralytic ileus.

Area of Science:

  • Gastroenterology
  • Surgical Research
  • Neurogastroenterology

Background:

  • Abdominal surgery frequently leads to postoperative gastrointestinal dysmotility and paralytic ileus.
  • This is attributed to inflammatory responses that damage interstitial cells of Cajal (ICC), essential for intestinal pacemaker activity.

Purpose of the Study:

  • To investigate the protective role of inducible nitric oxide synthase (iNOS) deficiency or inhibition against postsurgical damage to ICC and intestinal pacemaker function.
  • To explore the impact of iNOS and cyclooxygenase-2 (COX-2) on the widespread disruption of ICC networks and pacemaking post-surgery.

Main Methods:

  • Resection and end-to-end anastomosis of ileal segments in wild-type, iNOS knockout, and COX-2 knockout mice.
  • Administration of iNOS inhibitors to wild-type mice prior to surgery.
  • Assessment of electrical activity and ICC integrity 5 hours post-surgery.

Main Results:

  • Intestinal surgery significantly reduced ICC and pacemaking in wild-type mice up to 5 cm from the anastomosis.
  • ICC networks and pacemaking were preserved in iNOS knockout mice.
  • Preoperative iNOS inhibition protected pacemaker activity, with depression limited to the anastomosis site. COX-2 deficiency also reduced disruption.

Conclusions:

  • Absence or inhibition of nitric oxide (NO) derived from iNOS significantly attenuates damage to ICC and pacemaking post-surgery.
  • Preoperative management of iNOS activity is a promising strategy to protect against postsurgical dysmotility and reduce paralytic ileus severity.